Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ramoner

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Cancer|January 6, 1997
Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cellsM Thurnher, R Ramoner, G Gastl, et al.
Experimental Hematology|March 1, 1997
In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapyM Thurnher, C Papesh, R Ramoner, et al.
International Journal of Cancer|September 27, 1996
Human renal-cell carcinoma tissue contains dendritic cellsM Thurnher, C Radmayr, R Ramoner, et al.
Urologia Internationalis|March 30, 2000
Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinomaC Rieser, R Ramoner, L Höltl, et al.
The Journal of Urology|February 18, 1999
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cellsL Höltl, C Rieser, C Papesh, et al.
Cancer Gene Therapy|August 5, 2000
Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotidesI E Eder, Z Culig, R Ramoner, et al.
Urologia Internationalis|January 1, 1997
Dendritic cells for the immunotherapy of renal cell carcinomaM Thurnher, H Klocker, C Papesh, et al.
The Journal of Urology|May 9, 2001
Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinomaC Zelle-Rieser, A L Barsoum, F Sallusto, et al.
British Journal of Cancer|October 29, 1998
Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cellsZ Culig, A Hobisch, M Herold, et al.
The Prostate|June 1, 1997
Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostateM V Cronauer, A Hittmair, I E Eder, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|January 6, 1997
Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cellsM Thurnher, R Ramoner, G Gastl, et al.
Experimental Hematology|March 1, 1997
In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapyM Thurnher, C Papesh, R Ramoner, et al.
International Journal of Cancer|September 27, 1996
Human renal-cell carcinoma tissue contains dendritic cellsM Thurnher, C Radmayr, R Ramoner, et al.
Urologia Internationalis|March 30, 2000
Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinomaC Rieser, R Ramoner, L Höltl, et al.
The Journal of Urology|February 18, 1999
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cellsL Höltl, C Rieser, C Papesh, et al.
Cancer Gene Therapy|August 5, 2000
Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotidesI E Eder, Z Culig, R Ramoner, et al.
Urologia Internationalis|January 1, 1997
Dendritic cells for the immunotherapy of renal cell carcinomaM Thurnher, H Klocker, C Papesh, et al.
The Journal of Urology|May 9, 2001
Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinomaC Zelle-Rieser, A L Barsoum, F Sallusto, et al.
British Journal of Cancer|October 29, 1998
Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cellsZ Culig, A Hobisch, M Herold, et al.
The Prostate|June 1, 1997
Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostateM V Cronauer, A Hittmair, I E Eder, et al.
Pageof 3